risk stratification
Hackensack Meridien Health Launches Cancer Risk, Early Detection Program; Eyes Multi-Cancer Testing
Premium
Patients will be offered germline genetic testing after an assessment that includes genetic, lifestyle, and other clinical risk factor analysis.
A computationally derived score captured the severity, progression, and underdiagnosis of coronary artery disease.
UK's NICE Expands Tumor Profiling Recommendations for Guiding Adjuvant Chemo in Early Breast Cancer
Previously, NICE recommended EndoPredict, Prosigna, and Oncotype DX for node-negative breast cancer only, but the new guidance includes lymph node-positive disease.
Trial Failure Raises Questions About MRD Testing Utility, but Prognostic Evidence Remains Strong
Presentations at last week's ASCO GI meeting highlighted the ongoing generation of promising data for ctDNA-based minimal residual disease testing despite recent missteps.
Healthy Nevada Researchers Consider Impact of Low Genetic Breast Cancer Risk on Screening Guidelines
Premium
Identifying a low genetic risk group could more precisely inform when patients should start mammograms and other preventive practices, a study suggests.
Apr 26, 2023
Jan 17, 2023
Aug 27, 2021
Jun 30, 2021